Citation: | MA Cunliang, GENG Qingya. Evaluation value of serum microRNA-19b-3p and microRNA-933 levels on cardiac function and prognosis in elderly patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 63-67. DOI: 10.7619/jcmp.20233416 |
To investigate the evaluation value of serum microRNA-19b-3p (miR-19b-3p) and microRNA-933 (miR-933) levels on cardiac function and prognosis in elderly patients with chronic heart failure.
A total of 108 elderly patients with chronic heart failure were selected as study group. According to the New York Heart Society (NYHA) classification, 35 patients of the study group were classified into grade Ⅱ, 40 patients were classified into grade Ⅲ, and 33 patients were classified into grade Ⅳ. A total of 90 healthy people who underwent physical examination during the same period were selected as control group. Serum miR-19b-3p and miR-933 levels were detected after admission. Cardiac function parameters [left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDD)] were measured by echocardiography. The relationship between serum miR-19b-3p, miR-933 and cardiac function was analyzed by Pearson correlation method. Elderly patients with chronic heart failure were divided into occurrence group (n=34) and non-occurrence group (n=74) according to whether endpoint events occurred within one year of admission. The predictive value of serum miR-19b-3p and miR-933 in elderly patients with chronic heart failure was evaluated by receiver operating characteristic (ROC) curve. Multivariate Cox regression analysis was used to analyze the prognostic factors of elderly patients with chronic heart failure.
Serum levels of miR-19b-3p and miR-933 in the study group were significantly lower than those in the control group (P < 0.05). The levels of serum miR-19b-3p, miR-933 and LVEF in patients with cardiac function grade Ⅳ were significantly lower than those in patients with cardiac function grade Ⅲ, grade Ⅱ and healthy population, and LVEDD was larger than that in patients with cardiac function grade Ⅲ, patients with cardiac function grade Ⅱ and healthy population (P < 0.05). Serum miR-19b-3p level was positively correlated with LVEF and negatively correlated with LVEDD in elderly patients with chronic heart failure (r =0.554, -0.368, P < 0.001). Serum miR-933 level was positively correlated with LVEF and negatively correlated with LVEDD (r=0.505, -0.410, P < 0.001). The levels of serum miR-19b-3p and miR-933 in the occurrence group were significantly lower than those in the non-occurrence group (P < 0.05). The area under the curve (AUC) of serum miR-19b-3p and miR-933 to predict the prognosis of chronic heart failure in elderly patients were 0.835 (95%CI, 0.785 to 0.885) and 0.843 (95%CI, 0.790 to 0.890), and the AUC of the combined prediction was 0.901 (95%CI, 0.851 to 0.951). Serum miR-19b-3p (HR=3.762, 95%CI, 1.854 to 7.634), miR-933 (HR=3.480, 95%CI, 1.903 to 6.364) and National Institutes of Health Stroke Scale (NIHSS) score (HR=3.047, 95%CI, 1.837 to 5.051) were the prognostic factors of chronic heart failure in the elderly (P < 0.05).
Serum miR-19b-3p and miR-933 levels are low in elderly patients with chronic heart failure. The changes of miR-19b-3p and miR-933 levels are closely related to cardiac function and prognosis, which can be used as effective indicators to predict poor prognosis in elderly patients with chronic heart failure.
[1] |
孙君怡, 薛睿聪, 梁玮昊, 等. 慢性心力衰竭的诊疗现状[J]. 自然杂志, 2022, 44(2): 126-148. https://www.cnki.com.cn/Article/CJFDTOTAL-ZRZZ202202007.htm
|
[2] |
晏强, 邹耀霜, 眭维国, 等. MicroRNA在肾脏疾病和生理中的研究进展[J]. 医学综述, 2018, 24(3): 428-433. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZS201803003.htm
|
[3] |
FISCHER S, MATHIAS S, STADERMANN A, et al. Loss of a newly discovered microRNA in Chinese hamster ovary cells leads to upregulation of N-glycolylneuraminic acid sialylation on monoclonal antibodies[J]. Biotechnol Bioeng, 2022, 119(3): 832-844. doi: 10.1002/bit.28015
|
[4] |
康雪雪, 贺琳娟, 王远照, 等. 血清人微小RNA-17-5p和人微小RNA-19b-3p表达与儿童哮喘的关系[J]. 江苏医药, 2018, 44(7): 746-749, 853. https://www.cnki.com.cn/Article/CJFDTOTAL-YIYA201807005.htm
|
[5] |
ZHU X Q, SHAO P, TANG Y C, et al. hsa_circRNA_100533 regulates GNAS by sponging hsa_miR_933 to prevent oral squamous cell carcinoma[J]. J Cell Biochem, 2019, 120(11): 19159-19171. doi: 10.1002/jcb.29245
|
[6] |
KLEIMAN N S, RODRIGUEZ A R, RAIZNER A E. Interobserver variability in grading of coronary arterial narrowings using the American College of Cardiology/American Heart Association grading criteria[J]. Am J Cardiol, 1992, 69(4): 413-415. doi: 10.1016/0002-9149(92)90245-T
|
[7] |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2014[J]. 中华心血管病杂志, 2014, 42(2): 98-122. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYW201910003.htm
|
[8] |
何香, 张郁青. MiRNA-208水平与老年慢性心力衰竭病人心功能及临床预后的关系[J]. 实用老年医学, 2022, 36(6): 603-605. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLA202206014.htm
|
[9] |
ŠPINAR J, ŠPINAROVÁ L, VÍTOVEC J. Pathophysiology, causes and epidemiology of chronic heart failure[J]. Vnitr Lek, 2018, 64(9): 834-838. doi: 10.36290/vnl.2018.114
|
[10] |
董斐斐, 董少华, 单兴华, 等. MicroRNA与心血管疾病研究进展[J]. 中华保健医学杂志, 2019, 21(2): 190-192. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJB201902033.htm
|
[11] |
宿宁, 田猛, 罗玉梅, 等. 微RNA在心力衰竭病理生理进程中的研究进展[J]. 医学综述, 2018, 24(1): 46-50. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZS201801009.htm
|
[12] |
蒋健刚, 季宁宁, 杜晓马, 等. miRNA-155对慢性心力衰竭的诊断效能及其与β-catenin mRNA通路的相关性研究[J]. 浙江医学, 2021, 43(1): 33-36. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYE202101007.htm
|
[13] |
朱彤, 路艳, 刘春苗, 等. 慢性心衰患者miRNA-133、HE4、HO-1水平变化及其与心功能的相关性[J]. 医学临床研究, 2019, 36(6): 1123-1124.
|
[14] |
李万里. 血清miR-19b-3p对阿尔茨海默病大鼠认知水平的影响[J]. 锦州医科大学学报, 2020, 41(2): 15-18. https://www.cnki.com.cn/Article/CJFDTOTAL-JZYX202002004.htm
|
[15] |
林燕仔, 张光星, 郑婉, 等. 急性心肌梗死并发医院感染患者外周血miR-19b和IL-37水平及预后影响因素[J]. 中华医院感染学杂志, 2021, 31(11): 1629-1633. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY202111006.htm
|
[16] |
白石, 谷颖, 严明强. 老年急性心肌梗死外周血中的miR-19b、miR-208水平及其对30 d病死率的预测价值研究[J]. 中国急救复苏与灾害医学杂志, 2022, 17(11): 1409-1412. https://www.cnki.com.cn/Article/CJFDTOTAL-YTFS202211003.htm
|
[17] |
韩京军, 张艳炜, 张磊, 等. 微小RNAs对肺癌细胞系侵袭、迁移及凋亡的影响[J]. 解剖学报, 2020, 51(3): 392-397. https://www.cnki.com.cn/Article/CJFDTOTAL-JPXB202003015.htm
|
[18] |
王双双, 张斌强, 钱航, 等. 血清miR-92a、miR-17、miR-19b对冠心病患者冠状动脉病变程度的评估价值[J]. 山东医药, 2023, 63(7): 76-79. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY202307018.htm
|
[19] |
朱宏文, 喻溥蛟, 许嘉鸿. MiR-19b通过激活Akt信号通路保护心肌细胞凋亡[J]. 上海大学学报: 自然科学版, 2019, 25(1): 10-17. https://www.cnki.com.cn/Article/CJFDTOTAL-SDXZ201901002.htm
|
[20] |
阳慧, 苏雨江, 钟江华, 等. MiR-506-3p靶向TRAF6抑制心肌炎的炎性反应和心肌细胞凋亡[J]. 中国老年学杂志, 2019, 39(19): 4813-4817. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ201919063.htm
|
[21] |
阮怀玉, 廖小婷, 曾彬. MiR-19b对H2O2诱导的大鼠心肌细胞H9c2氧化应激损伤的保护作用及机制研究[J]. 心血管病学进展, 2021, 42(2): 177-182. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGB202102022.htm
|
[22] |
李海洲, 张艳炜, 许英杰, 等. MiR-933调控KLF6基因影响非小细胞肺癌的作用研究[J]. 中国癌症杂志, 2021, 31(7): 581-588. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ202107004.htm
|